• ASBMB 2016 Annual Meeting

Translational Scientist: Integrating Science and Medicine

SEBM/EBM Symposium 2016
      Guest Society of the American Society of Biochemistry and Molecular Biology

Symposium Organizers: H. Rex Gaskins, University of Illinois at Urbana-Champaign, and Warren E. Zimmer, Texas A&M Health Science Center
Sunday, April 3, 2016; 4:00pm - 6:15pm
San Diego Convention Center, Room 1A

The recent convergence of long established biomedical disciplines has created an explosion of technologies and methods resulting in remarkable innovations that possibly can be directly applied to enhance human health.  It is clear that the application of interdisciplinary science has led to a better and more complete understanding of certain diseases, yet the scientist and clinician often have different goals and speak different languages.  Advances in scientific endeavors lead to greater knowledge and at the same time adds to the complexity of comprehending the utility of the gained knowledge.  Thus, the idea of a multi-disciplinary person to “translate” scientific findings for improved health care was born, the “Translational Scientist” focusing upon bringing innovations from the bench to the patient bedside.  The importance of multi-disciplinary approach can be measured by the increased awareness and funding vehicles offered through public and private agencies and the development of many new journals devoted to the subject.  As the complexities of healthcare increase, moving towards an era of personalized medicine, there is a premium of having professionals to bridge the interface between patient care and bench research, interact effectively with the spectrum of healthcare providers and community members, and function efficiently within large research teams.  Thus the integration of science and medicine requires interdisciplinary, collaborative training of clinical and basic scientist utilizing innovative funding and training mechanisms and seeking alternatives to traditional teaching concepts.  Further, implementation of integrative health care pathways will require forging new partnerships between academia, industry and clinical sciences. 

The 2016 SEBM Symposium, “Translational Scientist: Integrating Science and Medicine”, will focus on key concepts of the translation of discovery to health care by way of presentations from the  NIH directorate, emphasizing the role of the NIH in driving the training of the healthcare workforce and advocating collaborative science; Dr. Michael Friedlander, Executive Director, Virginia Tech Carilion Research Institute, Associate Provost for Health Sciences and Senior Dean for Research, Virginia Tech Carilion School of Medicine, speaking on new and innovative approaches in medical education driving collaborative learning of clinical scientist; and Dr. Michael Wood, Licensing and Collaboration Director, AstraZeneca Neuroscience, articulating innovative approaches to forge new interactions between academic, industry, and clinical partners to continue moving health care through collaboration and discovery. 

Invited Speakers:

New Approaches in Medical Training of Health Researchers
Michael J. Friedlander, Virginia Tech Carilion Research Institute

Associate Provost for Health Sciences and Senior Dean for Research

Forging Interactions Between Academia, Industry and Clinical Health Care Providers
Michael Wood, AstraZeneca Neuroscience

Licensing and Collaboration Director